@article{79c85e875dd3412f98688fcc8a78b607,
title = "Covid-19: Time for a paradigm change",
keywords = "Acute Lung Injury/immunology, Anaphylaxis/immunology, Antibodies, Monoclonal/therapeutic use, Antiviral Agents/therapeutic use, Betacoronavirus/drug effects, COVID-19, Complement C5a/antagonists & inhibitors, Coronavirus Infections/drug therapy, Cytokine Release Syndrome/immunology, Cytokines/antagonists & inhibitors, Disease Progression, Gene Expression Regulation, Host-Pathogen Interactions/genetics, Humans, Lymphocytes/drug effects, Molecular Targeted Therapy/methods, Pandemics, Pneumonia, Viral/drug therapy, SARS-CoV-2, Severity of Illness Index, Signal Transduction",
author = "Buonaguro, {Franco M} and Ascierto, {Paolo A} and Morse, {Gene D} and Luigi Buonaguro and Igor Puzanov and Tornesello, {Maria Lina} and Christian Br{\'e}chot and Gallo, {Robert C}",
year = "2020",
month = sep,
doi = "10.1002/rmv.2134",
language = "English",
volume = "30",
pages = "e2134",
journal = "Reviews in Medical Virology",
issn = "1052-9276",
publisher = "John Wiley and Sons Ltd",
number = "5",
}